Robert Canada is a Nephrology physician affiliated with University of Tennessee Health Science Center. OpenAlex indexes 28 publications with 554 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1325 Eastmoreland Ave Ste 445
Memphis, TN 381047536
Telephone
901-866-8810Provider last certified this registry record 26 Feb 2025.
Industry payments
32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Vantive US Healthcare LLCProgram year20259 payments
- Bayer Healthcare Pharmaceuticals Inc.Program year202517 payments
- Ardelyx, Inc.Program year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
56.3%Calcium channel blocker11.7%Amlodipine Besylate100%Part D≥41 patientsBeta blocker9.5%Carvedilol53%Metoprolol Succinate30%Metoprolol Tartrate17%Part D<11 patients+ 9 more classes in this area
Metabolism & gastrointestinal
24.8%SGLT2 inhibitor11.3%Farxiga75%Jardiance25%Part D<11 patientsCorticosteroid4.7%Prednisone100%Part D≥14 patients+ 3 more classes in this area
Other
9.1%Phosphate Binder4.5%Sevelamer Carbonate100%Part D≥21 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia4.5%Velphoro100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluation of the Effect of Racial Differences on Longitudinal Trajectories of Kidney Function in People with HIV (PWH) on Tenofovir Alafenamide (TAF)-Based Antiretroviral Treatment (ART) Regimens
Journal of the American Society of Nephrology
2024 - Levetiracetam pharmacokinetics in critically ill patients undergoing renal replacement therapy
Journal of Critical Care
2020 - Acute kidney injury following coronary revascularization procedures in patients with advanced CKD
Nephrology Dialysis Transplantation
2018 - Predialysis coronary revascularization and postdialysis mortality
Journal of Thoracic and Cardiovascular Surgery
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Csaba Kovesdy, MD
University of Tennessee Health Science Center
Samuel Dagogo-Jack, MD
University of Tennessee Health Science Center
Lucas Elijovich, MD
University of Tennessee Health Science Center
Carmine Zoccali
University of Tennessee Health Science Center
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”